Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Nature Careers
- Stanford University
- University of North Carolina at Chapel Hill
- Rutgers University
- Loyola University
- Duke University
- Karolinska Institutet (KI)
- University of Luxembourg
- CNRS
- Indiana University
- Northeastern University
- Technical University of Munich
- UNIVERSITY OF HELSINKI
- University of Antwerp
- University of California, Los Angeles
- University of Southern Denmark
- University of Utah
- Adam Mickiewicz University, Poznań
- Amsterdam UMC
- Duke University Medical Center
- ETH Zürich
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- Fondation Hôpital Rothschild
- Heidelberg University
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- IMT Mines Ales
- Institute of Animal Reproduction and Food Research of Polish Academy of Sciences
- Lunds universitet
- SUNY University at Buffalo
- SciLifeLab
- Umeå universitet stipendiemodul
- University Miguel Hernandez
- University at Buffalo
- University of Florida
- University of Glasgow
- University of Kansas Medical Center
- University of Maryland, Baltimore
- University of Minnesota
- University of Nevada Las Vegas
- University of Newcastle
- Utrecht University
- VIB
- 32 more »
- « less
-
Field
-
system (CNS). We aim to uncover the principles of gene expression regulation during development and repurpose them for regeneration. We use a multidisciplinary approach that involves stem cell biology
-
- and stem cell biology, and great synergy with renowned research groups. More information on the IMMENS and open positions available at the Åbo Akademi University in Turku can be found here: https
-
metabolism and drug transport. Examples of this include cell-based models such as induced-pluripotent stem cells, primary human hepatocytes, and clinical studies. The pharmacoepidemiological research group
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 22 days ago
. The goals of the Rich Lab are to identify novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the prism of stem cell biology to identify core regulatory
-
models using induced pluripotent stem cell (iPSC)-derived kidney organoids. A key aspect of this work will involve integrating bioprinting and organ-on-chip technologies to create mature and
-
of cellular senescence, including senescence in stem cells, and identifying novel approaches to reduce the senescent cell burden. The candidate will join an exciting research environment in
-
the liver microenvironment. Experiments will utilize animal models, cell culture including induced pluripotent stem cells, and human patient samples. Required Qualifications: Applicants should hold a PhD
-
sensing Precision biomolecule processing for single-molecule technologies 3D tissue engineering with stem cells Synthetic and hybrid tissue engineering Versatile nanopore devices for sensing, sequencing
-
., Alzheimer’s or Parkinson’s) and a track record of first author publications, a plus. Experience with the development and validation of advanced cellular models, such as induced pluripotent stem cell–derived
-
of scientific publications in relevant fields. Experience with models of myopathies or inflammation. Familiarity with stem cell-derived muscle models or 3D culture systems (including physiological